HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
Immunotherapy (CAR T, Bispecifics and more) Treatment Chapter
Immunotherapy (CAR T, Bispecifics and more) Treatment Chapter  image

2399 members

The purpose of this chapter is to support and educate myeloma patients about new immunotherapies that are obtaining FDA approval or those that are still in clinical trials. This chapter will include discussion about CAR T therapy, antibody drug conjugates, bispecific antibodies, trispecific antibodies, vaccines, NK cell approaches and more. 


Chapter Events

No Upcoming Events

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology

Follow Us

facebook instagram twitter youtube